FDA Stamps Recall Of Teleflex Percutaneous Thrombolytic Device As Class I

The US FDA has designated a September recall by Teleflex of its Arrow-Trerotola Over-The-Wire PTD Kit Percutaneous Thrombolytic Device: 7FR as high-risk class I.

Teleflex
• Source: Alamy

The US Food and Administration has slapped its most severe classification, class I, on a recall of Teleflex’s Arrow-Trerotola Over-The-Wire PTD Kit Percutaneous Thrombolytic Device: 7FR. The product works in conjunction with the Arrow Rotator Drive Unit to clear clotted native arterio-venous fistulae and synthetic dialysis grafts.

Teleflex initiated its recall in September through a field safety corrective action after receiving reports that the inner orange...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Recalls

More from Policy & Regulation